ESMERALDA GUERRERO: Open Payments
NPI 1487905543 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 39 payments from 14 companies in 2025. Trend: 2023 $725 · 2024 $920 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $238 |
| Amgen Inc. | 5 | $228 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $137 |
| AstraZeneca Pharmaceuticals LP | 3 | $127 |
| ViiV Healthcare Company | 1 | $125 |
| PFIZER INC. | 5 | $112 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Boston Scientific Corporation | 1 | $29 |
| VIVUS LLC | 1 | $22 |
Products named: Ozempic, REPATHA, Kerendia, AIRSUPRA, APRETUDE, GEMTESA, OTEZLA, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
